By this fiscal, Lupin purposes to launch new products across geographies

Lupin is planning to launch its first biosimilar product and commercialise its first inhalation product in the United States of America (USA) in the current fiscal.

Glenmark's Angina treatment drug gets approval from USFDA

Glenmark Pharmaceuticals received final approval from USFDA for its Ranolazine extended-release tablets used for treatment of chronic angina.

Indian pharma industry to grow at 11-13 per cent in FY20

Indian pharmaceutical industry is expected to grow at 11-13 per cent in the current financial year: ICRA.

Sun Pharma arm enters pact with China Medical System

Sun Pharma’s wholly owned subsidiary and China Medical System’s subsidiary has entered into licensing agreement to commercialise and develop dermatology products like Tildrakizumab in G...

Transasia announces Rs 50 cr expansion plan in Sikkim unit

Kolkata: India's Leading In-vitro diagnostic company Transasia Bio-Medicals Ltd has approved a Rs 50 crore (US$ 7.15 million) investment for the expansion of its manufacturing ...

Cipla inks pact to acquire 26 pc stake in AMPSolar Power Systems

New Delhi: Indian pharmaceutical major Cipla Ltd has agreed to buy a 26 per cent stake in AMPSolar Power Systems Pvt Ltd for approximately Rs 12.90 crore (US$ 1.85 million).

Dr Reddys to spend upto USD 300 million on R&D in FY 20

New Delhi: Indian pharmaceutical major Dr Reddy's Laboratories is planning to invest up to US$ 300 million in research and development (R&D) in FY20.

Indian pharma exports hit US$ 19.14 bn, report double-digit growth after 3 yrs

Hyderabad: India’s pharmaceutical exports reached US$ 19.14 billion in FY19, growing in double digits at 10.72 per cent after three years, according to the Pharmaceutical Exp...